Literature DB >> 24128268

Dimensions of coping in chronic pain patients: factor analysis and cross-validation of the German version of the Coping Strategies Questionnaire (CSQ-D).

Martin Stoffel1, Dorota Reis2, Daniela Schwarz2, Annette Schröder2.   

Abstract

PURPOSE: The Coping Strategies Questionnaire (CSQ) by Rosenstiel and Keefe (1983) is one of the most widely used measures of coping strategies in pain patients, although its construct and factorial validity is dissatisfying. Verra, Angst, Lehmann, and Aeschlimann (2006) translated the full measure, which assesses eight different coping strategies, into German (CSQ-D). Our aim was to identify stable latent dimensions and present a shorter and more valid version of the CSQ-D.
METHODS: A principal axes factor analysis (PFA) and a confirmatory factor analysis (CFA) were performed for specification and cross-validation of the new model. Thus, two independent samples of patients with fibromyalgia-like symptoms (n = 321, n = 162) completed questionnaire batteries that included the CSQ-D and measures of fibromyalgia (FM) impact, pain, depression, and anxiety.
RESULTS: The most interpretable result appeared to be a six-factor model with an acceptable fit. The first four factors, (1) Catastrophizing, (2) Ignoring Pain, (3) Diversion, and (4) Reinterpreting Pain, resemble the original scales by Rosenstiel and Keefe (1983). The Praying or Hoping scale split up into distinct (5) Praying and (6) Hoping dimensions. Except Praying, all coping strategies were significantly associated with measures of psychological health outcomes, pain, overall FM impact, or social support.
CONCLUSIONS: The new short form, called CSQ-DS, is a valid and reliable instrument, composed of 26 items and assessing six coping strategies. Future investigations are recommended to further prove both the external and construct validity of the CSQ-DS. PsycINFO Database Record (c) 2013 APA, all rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24128268     DOI: 10.1037/a0034358

Source DB:  PubMed          Journal:  Rehabil Psychol        ISSN: 0090-5550


  7 in total

Review 1.  Psychosocial Adaptation to Disability Within the Context of Positive Psychology: Findings from the Literature.

Authors:  Erin Martz; Hanoch Livneh
Journal:  J Occup Rehabil       Date:  2016-03

2.  Chronic multisite pain in adolescent girls and boys with emotional and behavioral problems: the Young-HUNT study.

Authors:  Marit Skrove; Pål Romundstad; Marit S Indredavik
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-08-20       Impact factor: 4.785

3.  The social construction of fibromyalgia as a health problem from the perspective of policies, professionals, and patients.

Authors:  Erica Briones-Vozmediano
Journal:  Glob Health Action       Date:  2016-12-19       Impact factor: 2.640

4.  The social construction of fibromyalgia as a health problem from the perspective of policies, professionals, and patients.

Authors:  Erica Briones-Vozmediano
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

5.  Strategies for Coping with Chronic Lower Back Pain in Patients with Long Physiotherapy Wait Time.

Authors:  Anna Cabak; Anna Dąbrowska-Zimakowska; Aleksandra Truszczyńska; Patryk Rogala; Katarzyna Laprus; Wiesław Tomaszewski
Journal:  Med Sci Monit       Date:  2015-12-15

6.  Relevance of Religiosity for Coping Strategies and Disability in Patients with Fibromyalgia Syndrome.

Authors:  Alexandra Braun; Dimitar Evdokimov; Johanna Frank; Paul Pauli; Thomas Wabel; Nurcan Üçeyler; Claudia Sommer
Journal:  J Relig Health       Date:  2021-01-23

7.  Pain Management Strategies among Cancer Patients. Normalization of the CSQ (The Pain Coping Strategies Questionnaire) Form.

Authors:  Urszula Religioni; Aleksandra Czerw; Katarzyna Sygit; Krzysztof Zdziarski; Olga Partyka; Monika Pajewska; Anna Augustynowicz; Michał Waszkiewicz; Elżbieta Cipora; Ewa Ziółkowska; Dominika Mękal; Sylwia Jopek; Łukasz Strzępek; Tomasz Banaś
Journal:  Int J Environ Res Public Health       Date:  2022-01-17       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.